Murphy C J, Campbell S, Araki-Sasaki K, Marfurt C F
Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 53706, USA.
Cornea. 1998 Sep;17(5):529-36. doi: 10.1097/00003226-199809000-00011.
To determine the ability of norepinephrine to modulate proliferation, adhesion, and migration of SV-40 transformed human corneal epithelial cells.
Assays were performed using SV-40 transformed human corneal epithelial cells. For proliferation assays, cells were plated in 96-well plates coated with fibronectin and collagen (FNC). A dose-response curve was generated for norepinephrine in concentrations of 100 nM-100 microM. The cell number in each well was evaluated using the fluorochrome Calcein AM (an intracellular esterase cleavage substrate), and fluorescence was determined using an automated fluorescent plate reader. For cell adhesion, 25 x 10(-3) cells were plated onto FNC-coated 96-well plates, incubated in 10 nM-100 microM norepinephrine for 90 min, gently irrigated, and the remaining adherent cells quantitated. Cell migration was measured using blind-well migration chambers with a 10-microm pore size and FNC-coated filters. Cells (250 x 10(3)) were added to the upper chamber, incubated for 18 h in the presence of factors, after which time the cells that had migrated through the filter were quantitated. The toxicity of norepinephrine was evaluated using a standard Live/Dead assay employing the combined fluorochromes of ethidium homodimer (to indicate dead cells) and Calcein AM (to indicate viable cells). Varying concentrations of norepinephrine were added, and the cells incubated for 3 h and the fluorometric assay performed.
Norepinephrine stimulated corneal epithelial cell proliferation and migration over a wide range of concentrations. It did not modulate cell adhesion and demonstrated cell toxicity only at the highest (supraphysiologic) concentration tested.
Norepinephrine is normally found in the cornea and may be important in the maintenance of normal corneal homeostasis and in wound-healing processes.
确定去甲肾上腺素调节SV - 40转化的人角膜上皮细胞增殖、黏附和迁移的能力。
使用SV - 40转化的人角膜上皮细胞进行实验。对于增殖实验,将细胞接种于涂有纤连蛋白和胶原蛋白(FNC)的96孔板中。生成去甲肾上腺素浓度为100 nM - 100 μM的剂量反应曲线。使用荧光染料钙黄绿素AM(一种细胞内酯酶切割底物)评估每孔中的细胞数量,并使用自动荧光酶标仪测定荧光。对于细胞黏附,将25×10⁻³个细胞接种到涂有FNC的96孔板上,在10 nM - 100 μM去甲肾上腺素中孵育90分钟,轻轻冲洗,对剩余的贴壁细胞进行定量。使用孔径为10微米且涂有FNC的滤膜的盲孔迁移小室测量细胞迁移。将细胞(250×10³个)加入上室,在有因子存在的情况下孵育18小时,之后对穿过滤膜迁移的细胞进行定量。使用采用乙锭同二聚体(指示死细胞)和钙黄绿素AM(指示活细胞)组合荧光染料的标准活/死检测法评估去甲肾上腺素的毒性。加入不同浓度的去甲肾上腺素,将细胞孵育3小时并进行荧光测定。
去甲肾上腺素在广泛的浓度范围内刺激角膜上皮细胞增殖和迁移。它不调节细胞黏附,并且仅在测试的最高(超生理)浓度下表现出细胞毒性。
去甲肾上腺素通常存在于角膜中,可能在维持正常角膜内环境稳定和伤口愈合过程中起重要作用。